Piyush Mohan Srivastava

Prof. Dr. Piyush Mohan Srivastava

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2012 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
LKL. G. Kearney
L. G. Kearney
KLK. Lu
K. Lu
MOM. Ord
M. Ord
SPSheila Patel
Sheila Patel
KPK. Profitis
K. Profitis
PSPiyush Mohan Srivastava
Piyush Mohan Srivastava
Aims To assess the capacity of global longitudinal strain (GLS) in patients with aortic stenosis (AS) to (i) detect the subclinical left ventricular (LV) dysfunction [LV ejection fraction (LVEF) ≥50% patients]; (ii) predict all-cause mortality and major adverse cardiac events (MACE) (all patients), and (iii) provide incremental prognostic information over current risk markers. Methods and results Patients with AS ( n = 146) and age-matched controls ( n = 12) underwent baseline echocardiography to assess AS severity, conventional LV parameters and GLS via speckle tracking echocardiography. Baseline demographics, symptom severity class and comorbidities were recorded. Outcomes were identified via hospital record review and subject/physician interview. The mean age was 75 ± 11, 62% were male. The baseline aortic valve (AV) area was 1.0 ± 0.4 cm2 and LVEF was 59 ± 11%. In patients with a normal LVEF ( n = 122), the baseline GLS was controls −21 ± 2%, mild AS −18 ± 3%, moderate AS −17 ± 3% and severe AS −15 ± 3% ( P < 0.001). GLS correlated with the LV mass index, LVEF, AS severity, and symptom class ( P < 0.05). During a median follow-up of 2.1 (inter-quartile range: 1.8–2.4) years, there were 20 deaths and 101 MACE. Unadjusted hazard ratios (HRs) for GLS (per %) were all-cause mortality (HR: 1.42, P < 0.001) and MACE (HR: 1.09, P < 0.001). After adjustment for clinical and echocardiographic variables, GLS remained a strong independent predictor of all-cause mortality (HR: 1.38, P < 0.001). Conclusions GLS detects subclinical dysfunction and has incremental prognostic value over traditional risk markers including haemodynamic severity, symptom class, and LVEF in patients with AS. Incorporation of GLS into risk models may improve the identification of the optimal timing for AV replacement.

7 October 2014 in Echocardiography
Verified
Journal Article
Closed access
PDF file
KLKen J. Lu
Ken J. Lu
JCJanet X. C. Chen
Janet X. C. Chen
KPKonstantinos Profitis
Konstantinos Profitis
LKLeighton G. Kearney
Leighton G. Kearney
DDDimuth DeSilva
Dimuth DeSilva
PSPiyush Mohan Srivastava
Piyush Mohan Srivastava

1 February 2012 in American Journal of Hypertension
Verified
Journal Article
Closed access
SPSheila Patel
Sheila Patel
BWB. Wai
B. Wai
MOM. Ord
M. Ord
RMR. J. MacIsaac
R. J. MacIsaac
SGS. Grant
S. Grant
LBL. M. Burrell
L. M. Burrell
Cardiovascular disease is common in diabetes, and is associated with activation of the renin-angiotensin system (RAS). Angiotensin-converting enzyme (ACE)2 is a recently described member of the RAS, and this study investigated whether ACE2 polymorphisms are associated with hypertension, left ventricular (LV) mass, and cardiac function in type 2 diabetes. Variants in ACE2 (rs1978124, rs2074192, rs4240157, rs4646156, rs4646188) were examined in 503 Caucasian subjects with type 2 diabetes. As ACE2 is located on the X chromosome, analyses were performed separately for men and women. Hypertension was defined by a history of hypertension, and/or antihypertensive medications or blood pressure (BP) >130/80 mm Hg. LV mass and systolic function (ejection fraction) were assessed by transthoracic echocardiography. In men, hypertension was more prevalent with the ACE2 rs2074192 C allele (P = 0.023), rs4240157 G allele (P = 0.016) and rs4646188 T allele (P = 0.006). In men, the rs1978124 A allele was associated with a significantly lower ejection fraction compared to the G allele (62.3 ± 13.3 vs. 67.2 ± 10.9%, P = 0.002). This association remained significant after covariate adjustment for age, body mass index, hypertension, antihypertensive treatment, and BP. In women, the prevalence of hypertension was higher (P = 0.009) with the rs4240157 G allele, and the rs1978124 A allele was associated with significantly higher LV mass (P = 0.008). In Caucasians with type 2 diabetes, genetic variation in ACE2 is associated with hypertension and reduced systolic function in men, and hypertension and increased LV mass in women.

1 August 2010 in Kidney International
Verified
Journal Article
Closed access
SPSally A. Penfold
Sally A. Penfold
Melinda CoughlanMelinda Coughlan
Melinda Coughlan
SPSheila Patel
Sheila Patel
PSPiyush Mohan Srivastava
Piyush Mohan Srivastava
KSKarly C. Sourris
Karly C. Sourris
JFJosephine M Forbes
Josephine M Forbes

15 January 2008 in Clinical Science
Verified
Journal Article
Closed access
PSPiyush Mohan Srivastava
Piyush Mohan Srivastava
PCPaul Calafiore
Paul Calafiore
RMRichard J. Macisaac
Richard J. Macisaac
SPSheila Patel
Sheila Patel
MTMerlin Thomas
Merlin Thomas
LBLouise M Burrell
Louise M Burrell
The aim of the present study was to determine the prevalence and predictors of an abnormal echocardiogram in patients with Type 2 diabetes. Cardiac function and structure were rigorously assessed by comprehensive transthoracic echocardiographic techniques in 229 patients with Type 2 diabetes. Cardiovascular risk factors and diabetic complications were assessed, and predictors of an abnormal echocardiogram were identified using multivariate logistic regression analysis. An abnormal echocardiogram was present in 166 patients (72%). LVH (left ventricular hypertrophy) occurred in 116 patients (51%), and cardiac dysfunction was found in 146 patients (64%), of whom 109 had diastolic dysfunction alone and 37 had systolic±diastolic dysfunction. Independent predictors of an abnormal echocardiogram were obesity, age, the number of antihypertensive drugs used (all P<0.001) and creatinine clearance (P30; OR, 4.2 (95% CI, 1.9–9.0)] and by 80% for each antihypertensive agent used [OR, 1.8 (95% CI, 1.3–2.4) per agent]. In conclusion, an abnormal cardiac echocardiogram is common in patients with Type 2 diabetes. Importantly, although cardiac abnormalities can be predicted by traditional risk factors, such as age, obesity and renal function, the absence of micro- or macro-vascular complications does not predict a normal echocardiogram. We suggest that an echocardiogram identifies those with Type 2 diabetes at increased cardiovascular risk due to occult LVH and diastolic dysfunction, and this information may lead to more aggressive management of known risk factors in the clinic.

1 October 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
KLK.J. Lu
K.J. Lu
LKL.G. Kearney
L.G. Kearney
MOM. Ord
M. Ord
EJE. Jones
E. Jones
LBL.M. Burrell
L.M. Burrell
PSPiyush Mohan Srivastava
Piyush Mohan Srivastava